ABIVAX (EPA:ABVX) | WebDisclosure

PRESS RELEASE

published on 06/30/2026 at 22:48, 4 months 5 days ago

Abivax Announces Launch of Public Offering of American Depositary Shares
Abivax announces launch of public offering of American Depositary Shares for approximately $600 million to fund commercialization efforts and research expenses. Underwriters include Leerink Partners and Morgan Stanley

Funding Abivax Underwriters Public Offering American Depositary Shares
PRESS RELEASE

published on 06/30/2026 at 22:46, 4 months 5 days ago

Abivax annonce le lancement d’une offre au public d’American Depositary Shares
Abivax lance une offre publique d'American Depositary Shares d'une valeur d'environ 600 millions de dollars, pour financer ses traitements biotechnologiques innovants

Biotechnologie Financement Abivax Offre Publique American Depositary Shares
PRESS RELEASE

published on 06/30/2026 at 22:45, 4 months 5 days ago

Abivax annonce le lancement d’une offre au public d’American Depositary Shares
Abivax lance une offre publique d'American Depositary Shares pour environ 600 millions de dollars, côté Euronext Paris (FR0012333284 - ABVX) et NASDAQ

Euronext Paris Biotechnologie Abivax Offre Publique American Depositary Shares
BRIEF

published on 06/29/2026 at 22:52, 4 months 6 days ago

ABIVAX: Promising results from the ABTECT trial for ulcerative colitis

Security Abivax Obefazimod Ulcerative Colitis Clinical Trial
BRIEF

published on 06/29/2026 at 22:52, 4 months 6 days ago

ABIVAX: Résultats prometteurs de l'essai ABTECT pour la rectocolite hémorragique

Abivax Obefazimod Rectocolite Hémorragique Essai Clinique Sécurité
PRESS RELEASE

published on 06/29/2026 at 22:47, 4 months 6 days ago

Correction d’un communiqué du 29.06.2026 22:05 CET/CEST - ABIVAX: Résultats positifs de la partie 2 de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les ...
Abivax annonce des résultats positifs de la partie 2 de maintenance ABTECT démontrant un bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité de phase 3

Abivax Obefazimod Sécurité RCH Réfractaire Bénéfice Clinique
BRIEF

published on 06/29/2026 at 22:10, 4 months 6 days ago

ABIVAX: Positive results for obefazimod in refractory ulcerative colitis

Security Abivax Obefazimod Clinical Trial Refractory Ulcerative Colitis
BRIEF

published on 06/29/2026 at 22:10, 4 months 6 days ago

ABIVAX : Résultats positifs pour l'obéfazimod dans la RCH réfractaire

Abivax Obefazimod Essai Clinique Sécurité RCH Réfractaire
BRIEF

published on 06/29/2026 at 22:10, 4 months 6 days ago

Abivax annonce des résultats positifs de phase 3 pour l'obefazimod dans la colite ulcéreuse

Obefazimod Rectocolite Hémorragique Rémission Clinique Profil De Sécurité Résultats De La Phase 3
BRIEF

published on 06/29/2026 at 22:10, 4 months 6 days ago

Abivax Announces Positive Phase 3 Results for Obefazimod in Ulcerative Colitis

Obefazimod Ulcerative Colitis Phase 3 Results Safety Profile Clinical Remission

Published on 11/06/2026 at 01:20, 1 hour 38 minutes ago

Presentation to Munich Mining Conference
Published on 11/06/2026 at 00:53, 2 hours 5 minutes ago

Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 2 hours 13 minutes ago

Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/05/2026 at 23:55, 3 hours 3 minutes ago

Santé Canada autorise deux vaccins à ARNm de Moderna : un vaccin contre la grippe et un vaccin combiné contre la grippe et la COVID-19
Published on 11/05/2026 at 23:20, 3 hours 38 minutes ago

Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines

View all ACCESSWIRE

Published on 11/06/2026 at 00:05, 2 hours 53 minutes ago

RBI: Announcement of the result of the voluntary public tender offer for all Addiko shares following expiration of the grace period
Published on 11/05/2026 at 22:05, 4 hours 52 minutes ago

Quantinuum Reports Third Quarter 2026 Results and Raises Full-Year Revenue Outlook
Published on 11/05/2026 at 20:38, 6 hours 19 minutes ago

freenet uses funds from Ceconomy sale for waipu.tv acquisition and share buyback
Published on 11/05/2026 at 20:37, 6 hours 20 minutes ago

EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 75 million
Published on 11/05/2026 at 19:45, 7 hours 12 minutes ago

Stabilus SE fulfills forecast for fiscal 2026 and adjusts 2030 medium-term targets

View all EQS

Published on 11/05/2026 at 18:21, 8 hours 36 minutes ago

Capital et droits de vote au 31 octobre 2026
Published on 11/05/2026 at 18:21, 8 hours 36 minutes ago

Total number of voting rights and shares making up the share capital at October 31, 2026
Published on 11/05/2026 at 18:01, 8 hours 56 minutes ago

LNA SANTE : Chiffre d'Affaires T3 2026
Published on 11/05/2026 at 17:50, 9 hours 7 minutes ago

NRJ GROUP - Financial information Q3 2026
Published on 11/05/2026 at 17:50, 9 hours 7 minutes ago

NRJ GROUP - Information financière T3 2026

View all LES ECHOS COMFI WIRE

News